Growth of Hypertension Drug Market Forecast to 2025 in a Newly Released Report Profiling Pfizer Inc., Lupin Limited, Novartis AG, Ranbaxy Laboratories limited, AstraZenca plc., Johnson & Johnson Ltd.

The Global Hypertension Drug Market Size is observed to gain traction owing to various factors including rise in population count suffering from high blood pressure.

Hypertension is defined as a condition where arteries in the heart has continuously elevated pressure. It is also referred to as high blood pressure (HBP). According to American Heart Association 2017, hypertension is defined as a condition of blood pressure higher than 130 and 80 millimetres of mercury (mmHg). The measurement of blood pressure is expressed in terms namely; systolic pressure and diastolic pressure. An individual suffering from hypertension for long time has major risk of heart stroke, heart failure, atrial fibrillation, dementia, and vision loss.

Request sample copy of this report @ https://www.polarismarketresearch.com/industry-analysis/global-hypertension-drug-market/request-for-free-sample

Blood pressure is further categorized into primary high blood pressure and secondary high blood pressure. Primary high blood pressure holds the largest market share owing to its increasing number of cases due to changing lifestyle and various genetic factors. Primary hypertension is majorly influenced by the factors such as; excess salt in the diet, excess body weight, excessive intake of alcohol, and active or passive smoking. However, secondary high blood pressure accounts for a smaller market share. Secondary high blood pressures causes are easily identified that include chronic kidney disease, endocrine disorder, excess use of birth controlling pills.

According to Centres for Disease Control and Prevention (CDC), high blood pressure or hypertension is the major cause of heart disease, and heart stroke in the U.S. Moreover, approximately 32% of adults have high blood pressure in the U.S. which accounts for the ratio of 1 in every 3 adults. Additionally, high blood pressure is becoming one of the leading causes of death in North America during recent past.

Request For customization @ https://www.polarismarketresearch.com/industry-analysis/global-hypertension-drug-market/request-for-customization

Rising demand for effective treatment of high blood pressure and high number of drug patent expiration will support the growth of global market.
The global market is primarily driven by the factors such as growing number of patients suffering from high blood pressures globally. Hypertension majorly causes cardiovascular diseases like heart stroke, and heart failure which cause higher number of deaths. As per 2013 WHO reports, approximately 45% of heart related deaths were due to hypertension.

Moreover, the rising preference for the sedentary lifestyle in the developing countries is another factor contributing to the growth of hypertension cases.
Increasing expiry of patented drug has created lucrative opportunities in the existing market. In addition, increasing number and availability of generic drugs shall also boost the growth of this market. Also, the rising interest of local governments and their increased focus on patient assistance to propel the global market.

However, relative side effects by the use of hypertension drug and availability of alternative therapies in the developing countries can hinder growth of hypertension drug market in the near future.

Make Inquiry about this report @ https://www.polarismarketresearch.com/industry-analysis/global-hypertension-drug-market/inquire-before-buying

Global hypertension drug Market Taxonomy

The global hypertension drug market is segmented on the basis of hypertension type, therapy type, and geography.

On the basis of hypertension type, global hypertension drug market is segmented into:

• Primary High Blood Pressure
• Secondary High Blood Pressure

On the basis of therapy type, global hypertension drug market is segmented into:

• Beta Blockers Vasodilators
• Calcium Channel Blockers
• Angiotensin Converting Enzyme
• Diuretics
• Angiotensin Receptor Blockers
• Renin Inhibitors.

Geographically, the global hypertension drug market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Increased prevalence of hypertension and effective development of treatments to lead the global hypertension drug in North America.
Geographically, the market to be segmented as North America, Europe, Asia Pacific, Latin America & Middle East and Africa. Among the region, North America is expected to dominate this market during the forecast period. The North American region holds major share of this market owing to rising number of patients suffering from hypertension, and is one of the leading cause of death in this region. Also, increasing awareness for the use of alternative drugs, and increasing geriatric population in North America are factors enhancing the hypertension drug market in the near future.

However, Asia Pacific is expected to witness fast market growth during the forecast period. Increasing number of patients with hypertension, and rising awareness for the use of various drugs and therapies are the major factor anticipated to govern the global market during upcoming years.

Browse Complete Report Details @ https://www.polarismarketresearch.com/industry-analysis/global-hypertension-drug-market/

Key players in the global hypertension drug market are:

• Pfizer Inc.
• Lupin Limited
• Novartis AG
• Ranbaxy Laboratories limited
• AstraZenca plc.
• Johnson & Johnson Ltd.
• Boehringer Ingelheim
• Merck & Company
• Sanofi S.A.
• Daiichi-Sankyo
• Sun Pharmaceuticals LLC.

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.